Skip to main content
SGLT2 inhibitors improve cardiovascular outcomes across groups
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
SGLT2 inhibitors improve cardiovascular outcomes across groups
User login
Username
Password
Reset your password
Concept
Lead
score
Cardiovascular Risk Management
1
0.9
Type 2 Diabetes Mellitus
0
0.99
SGLT2 Inhibitor
0
0.86
Heart Failure (HF)
0
0.55
Heart
0
0.37
Coronary Artery Disease (CAD)
0
0.35
Meta-Analysis
0
0.25
Clinical Research
0
0.18
Angina Pectoris
0
0.06
Antianginals
0
0.06
Cardiovascular disease
0
0.06
Cerebrovascular Accident
0
0.06
Erectile Dysfunction
0
0.06
Fellowship
0
0.06
Hand
0
0.06
Illinois
0
0.06
Muscle
0
0.06
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Cardiology
0
0.9
Emergency Medicine
0
0.47
Pharmacist
0
0.1
Med Students
0
0.06
Neurology & Neurosurgery
0
0.06
Urology
0
0.06